Predictors of Outcomes in Pulmonary Hypertension of the Newborn

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 28
SponsorAssiut University

About this trial

This prospective cohort study aims to identify the clinical, laboratory, and echocardiographic predictors of outcomes among neonates diagnosed with persistent pulmonary hypertension of the newborn at Assiut University Children Hospital.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

- Neonates (term and preterm) admitted to the NICU

Clinical and echocardiographic evidence of pulmonary hypertension

Written informed consent from parents or legal guardians

Disqualifiers

- Major structural cyanotic congenital heart disease

Lethal congenital anomalies or chromosomal abnormalities incompatible with survival

Trial population

Term and preterm neonates admitted to the Neonatal Intensive Care Unit of Assiut University Children Hospital with clinical and echocardiographic evidence of persistent pulmonary hypertension.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

60 Participants
are grouped into 1 trial group
Group A: Single cohort: Neonates with PPHN

Trial outcomes

Primary outcomes

1

In-hospital mortality

Proportion of neonates with persistent pulmonary hypertension who die before hospital discharge.

Time frame
Up to 30 days

Secondary outcomes

1

Duration of mechanical ventilation

Total number of days of invasive mechanical ventilation.

Time frame
Up to 30 days
2

Duration of oxygen therapy

Total number of days requiring supplemental oxygen.

Time frame
Up to 30 days
3

Use of sildenafil

Proportion of neonates who receive sildenafil therapy.

Time frame
Up to 30 days
4

Use of inotropes

Proportion of neonates who receive inotropic support

Time frame
Up to 30 days

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: